Chinese biotechnology firm Realbio Technology has raised nearly RMB100 million (US$14.93 million) in a series A round of financing led by Chinese venture capital firm Shandong Luxin High-Tech Industry, according to a statement released on Wednesday.
Chinese Biotech Firm Realbio Raises Nearly $15M Series A+ Round comes originally from China Money Network. All Rights Reserved.